About Course #Y8006
Start Date: September 10, 2019
Expiration Date: September 10, 2022
Diabetes is a chronic disease state with no known cure. For this reason, diabetes management is intended to prevent complications and improve the patient's quality of life. If diabetes is left untreated or is poorly managed, the patient's disease may progress more rapidly or precipitate a hyperglycemic crisis, or the patient may experience treatment-related adverse events, such as hypoglycemia. As diabetes progresses, patients may develop diabetes complications or comorbid conditions, such as hypertension, hypercholesterolemia, cardiovascular disease, retinopathy, diabetic kidney disease, neuropathy, non-alcoholic fatty liver disease, gum disease, hearing loss, erectile dysfunction, and depression.
As a result of its high incidence and economic burden, diabetes management is an area of tremendous research. Many new pharmacotherapies have become available in recent years. The variety of options is ideal for patients with diabetes, but this vast array of choices may make treating diabetes daunting for healthcare providers. In addition, new guidelines for the treatment of diabetes have been released by both the American Diabetes Association and the American Association of Clinical Endocrinologists. In order to effectively manage patients with diabetes, it is important to stay current with the standard of care for treatment of diabetes and the therapeutic options available. This course provides a review the current treatment guidelines for diabetes management and the pharmacotherapies, both new and time-tested, available on the market today.
Universal Activity Number (UAN) - 0607-0000-19-006-H01-P
Type of Activity - Knowledge
Topic Designator - 01 - Disease State Management/Drug Therapy
- Recognize complications and comorbid conditions associated with diabetes.
- Identify appropriate treatment goals for a patient with diabetes.
- Recognize the time-action profiles and usual uses of insulin formulations.
- Compare and contrast the safety and efficacy of pharmacotherapies used in the management of diabetes.
- Identify adverse events that patients may experience while using pharmacotherapy for diabetes management and contraindications to therapy.
About the Author
Dhiren K. Patel, PharmD, CDE, BC-ADM, BCACP, is an associate professor of pharmacy practice in the School of Pharmacy - Boston at MCPHS University (formerly Massachusetts College of Pharmacy and Health Sciences). He also maintains a clinical practice site with the VA Boston Healthcare System, where he functions as a mid-level provider for a variety of chronic diseases such as diabetes, hypertension, dyslipidemia, and obesity. He earned his PharmD from MCPHS University and received his postdoctoral residency training at the VA Boston Healthcare System. He is also board-certified in advanced diabetes management (BC-ADM), as an ambulatory care pharmacist (BCACP), and as a diabetes educator (CDE).
- Courses must be completed on or before the expiration date noted in the course description above.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
- Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools' policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.
Find Diabetes Management: Pharmacotherapy Options for Diabetes Mellitus - Y8006 in your state
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Rhode Island
- South Carolina
- South Dakota
- West Virginia